MedPath

TABLOID

TABLOID brand Thioguanine 40-mg Scored Tablets

Approved
Approval ID

344df8bc-b16d-4b75-b4c8-40de7d465849

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2022

Manufacturers
FDA

Woodward Pharma Services LLC

DUNS: 080406260

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

thioguanine

PRODUCT DETAILS

NDC Product Code69784-630
Application NumberNDA012429
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateApril 15, 2022
Generic Namethioguanine

INGREDIENTS (6)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, POTATOInactive
Code: 8I089SAH3T
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
ACACIAInactive
Code: 5C5403N26O
Classification: IACT
THIOGUANINEActive
Quantity: 40 mg in 1 1
Code: FTK8U1GZNX
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TABLOID - FDA Drug Approval Details